23andMe Expands its Data Mining Operations
Personal genetics company 23andMe bought a patient social networking site called CureTogether earlier this week, a move that will expand the Silicon Valley-based company’s ability to mine data from its patients for its own research.
CureTogether is an online forum with some 25,000 members who share information about their illness, and personal anecdotes about the effects of treatments and lifestyle choices on their symptoms.
23andMe sells DNA tests directly to consumers who send a spit sample to the company for genomic screening of up to 1 million genetic variants, which are a mix of both recreational (e.g. the genetic basis for tongue rolling) and serious medical traits (e.g. genetic factors associated with Parkinson’s Disease) as well as variants that indicate a customer’s ancestry.
The amount of the purchase was not reported and is 23andMe’s first acquisition, according to the San Francisco Business Times.
Deep Dive
Biotechnology

The creator of the CRISPR babies has been released from a Chinese prison
He Jiankui created the first gene-edited children. The price was his career. And his freedom.

Aging clocks aim to predict how long you’ll live
These clocks promise to measure biological age and help identify anti-aging drugs, but there are lingering questions over their accuracy.

The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

A locked-in man has been able to communicate in sentences by thought alone
In a world first, the man was able to ask for soup, beer, and even talk about his son for the first time since becoming completely paralyzed.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.